1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Taihe Group, Inc.

Taihe Group, Inc.

TIHE
Taihe Group, Inc.US flagOther OTC
1.00
USD
- -
- -
71.85MMarket Cap
Taihe Group, Inc.
TIHE
(Other OTC)

Recent

price

1.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
TTM
FRC
- -
- -
- -
- -
Revenue per Share
- -
-7.48
- -
- -
Basic EPS, GAAP
- -
-7.48
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
Dividend per Share
-3,332.93
-2,777.91
-0.17
-0.13
Book Value per Share
- -
-0.13
- -
- -
Tangible Book Value per Share
- -
- -
63
81
Basic Weighted Avg Shares
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'22
Dec'22
Mar'23
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
100
100
100
Market Capitalization
14,253
75
260

Working Capital

FRC

•

in mil. unless spec.
Sep'22
Dec'22
Mar'23
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
43.33%
Net Income, GAAP
- -
- -
50.47%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
-7.48
2022
-3.13
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SS)
Rosetta Genomics Ltd. (ROSGQ)
Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
Tecan Group AG (0QLN.L)
BioPorto A/S (BIOPOR.CO)
Illumina, Inc. (ILMN)
Business
Taihe Group, Inc. (TIHE) engages in the development and construction of land and properties relating to tourism, integrating real estate and villas; hospitality services; and cargo freight logistics services. The company operates with no revenue from operations and maintains a minimal staff of three employees. Headquartered on Jalan Batu Licin, Indonesian Street City, Bintan Island (29151), it conducts activities primarily in Indonesia. Formerly known as NuOncology Labs Inc., the company shifted from providing predictive chemosensitivity and immunotherapy predictive tests for cancer treatment optimization to its current tourism and logistics focus. In February 2023, Taihe Group, Inc. and its wholly-owned subsidiary HuaYin entered into a Share Exchange Agreement to acquire PT entities, marking a significant expansion through business acquisitions. Leadership includes Chief Executive Officer Yan-Ping Sheng, aged 64, and Chairman Sunny Sukardi, aged 60, appointed in January 2023.